Related Articles by Review for PMID: 19815582

Year	Number of Results
2009	3
2010	1
2011	2
2012	2
2013	1
2014	2
2015	1
2016	2
2017	3
2018	3
2021	3
2022	1
2024	0

1

Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States.

Kim JJ, Goldie SJ. Kim JJ, et al. BMJ. 2009 Oct 8;339:b3884. doi: 10.1136/bmj.b3884. BMJ. 2009. PMID: 19815582 Free PMC article.

2

Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

Armstrong EP. Armstrong EP. J Manag Care Pharm. 2010 Apr;16(3):217-30. doi: 10.18553/jmcp.2010.16.3.217. J Manag Care Pharm. 2010. PMID: 20331326 Free PMC article. Review.

3

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].

Westra TA, Daemen T, Postma MJ, Wilschut JC. Westra TA, et al. Ned Tijdschr Geneeskd. 2009;153:A356. Ned Tijdschr Geneeskd. 2009. PMID: 19930733 Review. Dutch.

4

The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.

Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T, Atthobari J, Wilffert B, Postma MJ. Setiawan D, et al. Expert Rev Vaccines. 2015 Apr;14(4):589-604. doi: 10.1586/14760584.2014.990386. Epub 2014 Dec 6. Expert Rev Vaccines. 2015. PMID: 25482311 Review.

5

The cost effectiveness of human papillomavirus vaccines: a systematic review.

Seto K, Marra F, Raymakers A, Marra CA. Seto K, et al. Drugs. 2012 Mar 26;72(5):715-43. doi: 10.2165/11599470-000000000-00000. Drugs. 2012. PMID: 22413761 Review.

6

Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness.

Soe NN, Ong JJ, Ma X, Fairley CK, Latt PM, Jing J, Cheng F, Zhang L. Soe NN, et al. Hum Vaccin Immunother. 2018;14(12):3010-3018. doi: 10.1080/21645515.2018.1496878. Epub 2018 Sep 11. Hum Vaccin Immunother. 2018. PMID: 30024823 Free PMC article. Review.

7

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.

Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C. Brisson M, et al. Lancet Public Health. 2016 Nov;1(1):e8-e17. doi: 10.1016/S2468-2667(16)30001-9. Epub 2016 Sep 27. Lancet Public Health. 2016. PMID: 29253379 Free PMC article. Review.

8

Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis.

Tejada RA, Malagón T, Franco EL. Tejada RA, et al. Vaccine. 2022 Apr 26;40(19):2667-2678. doi: 10.1016/j.vaccine.2022.03.046. Epub 2022 Mar 31. Vaccine. 2022. PMID: 35370017 Review.

9

Cost-effectiveness of extending the HPV vaccination to boys: a systematic review.

Linertová R, Guirado-Fuentes C, Mar Medina J, Imaz-Iglesia I, Rodríguez-Rodríguez L, Carmona-Rodríguez M. Linertová R, et al. J Epidemiol Community Health. 2021 Sep;75(9):910-916. doi: 10.1136/jech-2020-216305. Epub 2021 Jun 23. J Epidemiol Community Health. 2021. PMID: 34162740 Review.

10

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review.

Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G. Marra F, et al. Pharmacoeconomics. 2009;27(2):127-47. doi: 10.2165/00019053-200927020-00004. Pharmacoeconomics. 2009. PMID: 19254046 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year